Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

One year in review 2019: systemic sclerosis.

Barsotti S, Orlandi M, Codullo V, Di Battista M, Lepri G, Della Rossa A, Guiducci S.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):3-14. Epub 2019 Oct 3. Review.

2.

Is there a role for laser speckle contrast analysis (LASCA) in predicting the outcome of digital ulcers in patients with systemic sclerosis?

Barsotti S, d'Ascanio A, Valentina V, Chiara S, Silvia B, Laura A, Mosca M, Della Rossa A.

Clin Rheumatol. 2020 Jan;39(1):69-75. doi: 10.1007/s10067-019-04662-7. Epub 2019 Jul 17.

PMID:
31317425
3.

Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study.

Negrini S, Magnani O, Matucci-Cerinic M, Carignola R, Data V, Montabone E, Santaniello A, Adorni G, Murdaca G, Puppo F, Indiveri F, Della Rossa A, D'Ascanio A, Barsotti S, Giuggioli D, Ferri C, Lumetti F, Bosello SL, Canestrari G, Bellando Randone S, Bruni C, Guiducci S, Battaglia E, De Andres MI, Russo AA, Beretta L.

Clin Exp Med. 2019 Aug;19(3):357-366. doi: 10.1007/s10238-019-00553-y. Epub 2019 Apr 15.

PMID:
30989453
4.

Systemic sclerosis: state of the art on clinical practice guidelines.

Smith V, Scirè CA, Talarico R, Airo P, Alexander T, Allanore Y, Bruni C, Codullo V, Dalm V, De Vries-Bouwstra J, Della Rossa A, Distler O, Galetti I, Launay D, Lepri G, Mathian A, Mouthon L, Ruaro B, Sulli A, Tincani A, Vandecasteele E, Vanhaecke A, Vanthuyne M, Van den Hoogen F, Van Vollenhoven R, Voskuyl AE, Zanatta E, Bombardieri S, Burmester G, Eurico FJ, Frank C, Hachulla E, Houssiau F, Mueller-Ladner U, Schneider M, van Laar JM, Vieira A, Cutolo M, Mosca M, Matucci-Cerinic M.

RMD Open. 2018 Oct 18;4(Suppl 1):e000782. doi: 10.1136/rmdopen-2018-000782. eCollection 2018.

5.

One year in review 2018: systemic sclerosis.

Orlandi M, Barsotti S, Lepri G, Codullo V, Di Battista M, Guiducci S, Della Rossa A.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):3-23. Epub 2018 Sep 28. Review.

6.

Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.

Tani C, Vagelli R, Stagnaro C, Carli L, Lorenzoni V, Drago F, Doherty W, McSorley MR, Marconcini L, Della Rossa A, Turchetti G, Mosca M.

Lupus. 2018 Sep;27(10):1735-1741. doi: 10.1177/0961203318785772. Epub 2018 Jul 25.

PMID:
30045666
7.

Muscular vasculitis confined to lower limbs: description of two case reports and a review of the literature.

Tripoli A, Barsotti S, Pollina LE, Della Rossa A, Neri R, d'Ascanio A, Baldini C, Mosca M.

Rheumatol Int. 2017 Dec;37(12):2115-2121. doi: 10.1007/s00296-017-3841-z. Epub 2017 Oct 16. Review.

PMID:
29038907
8.

One year in review 2017: systemic sclerosis.

Barsotti S, Bruni C, Orlandi M, Della Rossa A, Marasco E, Codullo V, Guiducci S.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):3-20. Epub 2017 Sep 29. Review.

9.

One year in review 2016: systemic sclerosis.

Barsotti S, Stagnaro C, d'Ascanio A, Della Rossa A.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):3-13. Epub 2016 Jul 18. Review.

10.

Post-occlusive reactive hyperaemia (POHR) in systemic sclerosis: very early disease (VEDOSS) represents a separate entity compared to established disease.

Della Rossa A, D'Ascanio A, Barsotti S, Stagnaro C, Mosca M.

Scand J Rheumatol. 2016 Oct;45(5):408-11. doi: 10.3109/03009742.2015.1127411. Epub 2016 Mar 7.

PMID:
26948487
11.

Systemic sclerosis: a critical digest of the recent literature.

Barsotti S, Stagnaro C, Della Rossa A.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S3-14. Epub 2015 Aug 5. Review.

PMID:
26243174
12.

Systemic vasculitides: a critical digest of the most recent literature.

Stagnaro C, Cioffi E, Talarico R, Della Rossa A.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-145-54. Epub 2015 May 26. Review.

PMID:
26016767
13.

Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients.

Barsotti S, Mattaliano V, d'Ascanio A, Mosti G, Della Rossa A, Mattaliano C, Giuggioli D, Giraldi E, Ferri C, Mosca M.

Int Wound J. 2016 Oct;13(5):1050-1. doi: 10.1111/iwj.12424. Epub 2015 Feb 3. No abstract available.

PMID:
25648085
14.

Systemic sclerosis: a critical digest of the recent literature.

Barsotti S, Bellando Randone S, Guiducci S, Della Rossa A.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S194-205. Epub 2014 Nov 5. Review.

PMID:
25372802
15.

Systemic vasculitis: an annual critical digest of the most recent literature.

Della Rossa A, Cioffi E, Elefante E, Ferro F, Parma A, Vagelli R, Talarico R.

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S98-105. Epub 2014 May 15. Review.

PMID:
24854379
16.

TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review.

Mosca M, Tani C, Filice ME, Carli L, Delle Sedie A, Vagnani S, Della Rossa A, Baldini C, Bombardieri S.

Mod Rheumatol. 2015 Jul;25(4):642-5. doi: 10.3109/14397595.2013.844306. Epub 2013 Nov 4. Review.

PMID:
24252029
17.

Occurrence of Hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis.

Carli L, Tani C, Vagnani S, Querci F, Baldini C, Talarico R, Della Rossa A, Bombardieri S, Mosca M.

Reumatismo. 2013 Oct 31;65(4):203-4. doi: 10.4081/reumatismo.2013.203. No abstract available.

PMID:
24192566
18.

Systemic sclerosis: a critical digest of the recent literature.

Tani C, Bellando Randone S, Guiducci S, Della Rossa A.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):172-9. Epub 2013 Jul 23. Review.

PMID:
23910620
19.

Systemic vasculitis: a critical digest of the recent literature.

Talarico R, Baldini C, Della Rossa A, Carli L, Tani C, Bombardieri S.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S84-8. Epub 2013 Apr 9. Review.

PMID:
23663686
20.

Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity.

Carli L, Tani C, Querci F, Della Rossa A, Vagnani S, Baldini C, Talarico R, d'Ascanio A, Neri R, Tavoni AG, Bombardieri S, Mosca M.

Clin Rheumatol. 2013 Jul;32(7):1071-3. doi: 10.1007/s10067-013-2214-6. Epub 2013 Mar 3.

PMID:
23456414
21.

Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.

Baldini C, Mosca M, Della Rossa A, Pepe P, Notarstefano C, Ferro F, Luciano N, Talarico R, Tani C, Tavoni AG, Bombardieri S.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2):272-80. Epub 2013 Jan 18.

PMID:
23343785
22.

Analysis of the evolution of UCTD to defined CTD after a long term follow-up.

Mosca M, Tani C, Carli L, Della Rossa A, Talarico R, Baldini C, Bombardieri S.

Clin Exp Rheumatol. 2013 May-Jun;31(3):471. Epub 2012 Oct 18. No abstract available.

PMID:
23075608
23.

Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?

Latorre M, Baldini C, Seccia V, Notarstefano C, Della Rossa A, Tani C, Talarico R, Mosca M, Paggiaro PL.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S91-2. Epub 2012 Oct 18. No abstract available.

PMID:
23075542
24.

Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis.

Della Rossa A, Cazzato M, d'Ascanio A, Tavoni A, Bencivelli W, Pepe P, Mosca M, Baldini C, Rossi M, Bombardieri S.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):109-14. Epub 2012 Oct 22.

PMID:
23073231
25.

Rhupus syndrome: assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients.

Tani C, D'Aniello D, Delle Sedie A, Carli L, Cagnoni M, Possemato N, Carbone M, Della Rossa A, Riente L, Baldini C, Talarico R, Caramella D, Bombardieri S, Mosca M.

Autoimmun Rev. 2013 Feb;12(4):537-41. doi: 10.1016/j.autrev.2012.09.004. Epub 2012 Oct 11.

PMID:
23063507
26.

Future prospects for salivary proteomics in rheumatology: the example of eosinophil granulomatosis with polyangiitis.

Martini D, Baldini C, Latorre M, Giorgerini V, Sernissi F, Della Rossa A, Mosca M.

Clin Exp Rheumatol. 2012 Sep-Oct;30(5):810-1. Epub 2012 Oct 17. No abstract available.

PMID:
23009806
27.

Long-term cyclic intravenous iloprost in systemic sclerosis: clinical experience from a single center.

Casigliani Rabl S, Della Rossa A, Pepe P, D'Ascanio A, Mosca M, Di Vita A, Bombardieri S.

Reumatismo. 2012 Jul 19;64(3):158-65. doi: 10.4081/reumatismo.2012.158.

PMID:
22842299
28.

Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature.

Talarico R, Baldini C, Della Rossa A, Stagnaro C, Ferrari C, Luciano N, Bombardieri S.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S130-8. Epub 2012 May 11. Review.

PMID:
22640656
29.

Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosis.

Manetti M, Allanore Y, Saad M, Fatini C, Cohignac V, Guiducci S, Romano E, Airó P, Caramaschi P, Tinazzi I, Riccieri V, Della Rossa A, Abbate R, Caporali R, Cuomo G, Valesini G, Dieudé P, Hachulla E, Cracowski JL, Tiev K, Letenneur L, Amouyel P, Lambert JC, Chiocchia G, Martinez M, Ibba-Manneschi L, Matucci-Cerinic M.

Ann Rheum Dis. 2012 Jun;71(6):1034-41. doi: 10.1136/annrheumdis-2011-200986. Epub 2012 Mar 8.

PMID:
22402147
30.

Oral sildenafil in skin ulcers secondary to systemic sclerosis.

Della Rossa A, Doveri M, D'Ascanio A, Tavoni A, Consensi A, Neri R, Bazzichi L, Bombardieri S.

Scand J Rheumatol. 2011;40(4):323-5. doi: 10.3109/03009742.2011.569755. Epub 2011 Jun 6. No abstract available.

PMID:
21639825
31.

A proposal of simple calculation (ERI calculator) to predict the early response to TNF-α blockers therapy in rheumatoid arthritis.

Bazzichi L, Rossi P, Giacomelli C, De Feo F, Bobbio-Pallavicini F, Rossi A, Baldini C, Consensi A, Doveri M, Bonino C, Mazzantini M, Della Rossa A, Montecucco C, Bombardieri S.

Rheumatol Int. 2012 Feb;32(2):349-56. doi: 10.1007/s00296-010-1619-7. Epub 2010 Nov 26.

PMID:
21110028
32.

Clinical manifestations and treatment of Churg-Strauss syndrome.

Baldini C, Talarico R, Della Rossa A, Bombardieri S.

Rheum Dis Clin North Am. 2010 Aug;36(3):527-43. doi: 10.1016/j.rdc.2010.05.003. Epub 2010 Jun 20. Review.

PMID:
20688248
33.

Endothelial progenitor cells in mixed cryoglobulinemia.

Marchi F, Chimenti D, Tavoni A, Della Rossa A, Bombardieri S, Migliorini P.

J Rheumatol. 2010 Jul;37(7):1505-7. doi: 10.3899/jrheum.100012. Epub 2010 Jun 1.

PMID:
20516023
34.

Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus.

Della Rossa A, Tavoni A, D'Ascanio A, Catarsi E, Marchi F, Bencivelli W, Salvadori S, Migliorini P, Bombardieri S.

Scand J Rheumatol. 2010 Mar;39(2):167-70. doi: 10.3109/03009740903313639.

PMID:
20337547
35.

How HCV has changed the approach to mixed cryoglobulinemia.

Della Rossa A, Baldini C, Tavoni A, Bombardieri S.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S115-23. Review.

PMID:
19646357
36.

Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy.

Della Rossa A, Neri R, Talarico R, Doveri M, Consensi A, Salvadori S, Lorenzoni V, Turchetti G, Bellelli S, Cazzato M, Bazzichi L, Monicelli P, Moscardini S, Bombardieri S.

Clin Rheumatol. 2010 Jan;29(1):71-81. doi: 10.1007/s10067-009-1285-x. Epub 2009 Oct 6.

PMID:
19806287
37.

Cell-free DNA in the plasma of patients with systemic sclerosis.

Mosca M, Giuliano T, Cuomo G, Doveri M, Tani C, Curcio M, Abignano G, De Feo F, Bazzichi L, Della Rossa A, Valentini G, Bombardieri S.

Clin Rheumatol. 2009 Dec;28(12):1437-40. doi: 10.1007/s10067-009-1245-5. Epub 2009 Aug 11.

PMID:
19669854
38.

[Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre].

Baldini C, Della Rossa A, Grossi S, Catarsi E, Talarico R, d'Ascanio A, Mosca M, Neri R, Tavoni A, Bombardieri S.

Reumatismo. 2009 Apr-Jun;61(2):118-24. Italian.

39.

Mixed cryoglobulinemia and mortality: a review of the literature.

Della Rossa A, Marchi F, Catarsi E, Tavoni A, Bombardieri S.

Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S105-8. Review.

PMID:
19026151
40.

[Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis].

Doveri M, Frassi F, Consensi A, Vesprini E, Gargani L, Tafuri M, Picano E, Della Rossa A, Delle Sedie A, d'Ascanio A, Giacomelli C, Bazzichi L, Bombardieri S.

Reumatismo. 2008 Jul-Sep;60(3):180-4. Italian.

41.

[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome].

Pugliese N, Bruzzone M, Della Rossa A, Baldini C, Catarsi E, Tavoni A, D'Ascanio A, Bombardieri S.

Reumatismo. 2008 Apr-Jun;60(2):120-4. Italian.

42.

[Analysis of the evolution to defined connective tissue diseases of patients with "early unidifferentiated connective tissue diseases (UCTD)"].

Mosca M, Tani C, Neri C, Craig F, Della Rossa A, Baldini C, Talarico R, Carli L, Bombardieri S.

Reumatismo. 2008 Jan-Mar;60(1):35-40. Italian.

43.

Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients.

Rossi M, Bazzichi L, Di Maria C, Franzoni F, Raimo K, Della Rossa A, Santoro G, Bombardieri S.

Rheumatology (Oxford). 2008 Jul;47(7):1012-7. doi: 10.1093/rheumatology/ken117. Epub 2008 Apr 22.

PMID:
18430760
44.

Comment on: disease activity criteria in scleroderma.

Della Rossa A, Bombardieri S, Valentini G.

Semin Arthritis Rheum. 2008 Feb;37(4):271-2; author reply 272. Epub 2007 Sep 24. No abstract available.

PMID:
17889262
45.

Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?

Della Rossa A, Tavoni A, Merlini G, Baldini C, Sebastiani M, Lombardi M, Neglia D, Bombardieri S.

Rheumatology (Oxford). 2005 Aug;44(8):1074-5. Epub 2005 Apr 19. No abstract available.

PMID:
15840604
46.

Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations.

Della Rossa A, Tavoni A, Bombardieri S.

Semin Thromb Hemost. 2003 Oct;29(5):473-7. Review.

PMID:
14631547
47.

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score.

Valentini G, D'Angelo S, Della Rossa A, Bencivelli W, Bombardieri S.

Ann Rheum Dis. 2003 Sep;62(9):904-5. No abstract available.

48.

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria.

Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ, Black CM, Czirjak L, Nielsen H, Vlachoyiannopoulos PG.

Ann Rheum Dis. 2003 Sep;62(9):901-3.

49.

Assessment of disease severity and prognosis.

Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W.

Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42-6. Review.

PMID:
12889222
50.

Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre.

Della Rossa A, Baldini C, Tavoni A, Tognetti A, Neglia D, Sambuceti G, Puccini R, Colangelo C, Bombardieri S.

Rheumatology (Oxford). 2002 Nov;41(11):1286-94.

PMID:
12422002

Supplemental Content

Loading ...
Support Center